Management of malignant teratoma: does referral to a specialist unit matter?

@article{Harding1993ManagementOM,
  title={Management of malignant teratoma: does referral to a specialist unit matter?},
  author={M. J. Harding and James Paul and Stanley B. Kaye and Charles R. Gillis},
  journal={The Lancet},
  year={1993},
  volume={341},
  pages={999-1002}
}
Management of ovarian cancer: referral to a multidisciplinary team matters.
TLDR
The results of this study support the contents of the 1991 Department of Health report on present acceptable practice in the management of ovarian cancer, circulated to gynaecologists and surgeons in Scotland in 1992.
A Scottish national mortality study assessing cause of death, quality of and variation in management of patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.
TLDR
A detailed casenote review was performed on 55 patients registered with testicular non-seminomatous germ cell tumours between 1983 and 1988 under the Scottish Cancer Registration Scheme and who had died by 1992, showing significant differences between centres.
Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration
TLDR
This report is a complete review of NSGCT patients treated in the authors' minor university clinic and survival rates are comparable to recently published data, due to a commitment to multicentre protocol and research collaboration.
Who should manage germ cell tumours of the testis?
  • Mead
  • Medicine
    BJU international
  • 1999
TLDR
This issue of BJU International contains two papers with conflicting messages, one on the management of testicular cancer and the other on morbidity and the financial and psychological cost of achieving cure.
Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
TLDR
The treatment outcome of a single institution in Japan is not different from that of the institutions participating in the International Germ Cell Cancer Consensus Group (IGCCCG) and the Indiana University classification.
Testicular Cancer
TLDR
The treatment of germ-cell tumours of the testis can be considered as a model for cancer management, representing public education, diagnosis and cure with long term follow-up, and more time can be spent reducing acute and late toxicity in long term survivors and studying sociopsychological aspects in these men.
Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.
TLDR
After 612 patient-years of observation no case of secondary leukaemia was observed among 119 surviving patients who had received etoposide as part of their treatment, indicating some evidence that cumulative experience translates into improved survival and cure rates for patients with poor-risk metastatic disease.
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference.
  • N. NicolaiD. Biasoni E. Benhamou
  • Medicine
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2019
...
...

References

SHOWING 1-10 OF 22 REFERENCES
Rare cancers and specialist centres.
TLDR
For patients with early disease the dispute over the relative merits of radiotherapy and surgery to the retroperitoneal lymph nodes has become outdated by advances in staging procedures and the dramatic effects of cytotoxic chemotherapy.
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party.
  • G. MeadS. Stenning P. Cook
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1992
TLDR
Assessment of prognostic factors in a large population of patients with metastatic nonseminomatous germ cell tumors arising in gonadal or extragonadal sites found a good-prognosis group having none of these features had a 3-year survival rate of 93%.
Changes in testicular cancer in Scotland.
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
  • N. AassO. Klepp S. Fosså
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1991
TLDR
Between 1981 and 1986, 200 consecutive patients with metastatic nonseminomatous testicular cancer were entered into the Swedish Norwegian Testicular Cancer project from 14 hospitals, and the overall 5-year survival rate was 82%.
Centralisation of treatment and survival rates for cancer.
  • C. Stiller
  • Medicine
    Archives of disease in childhood
  • 1988
TLDR
Children with acute non-lymphoblastic leukaemia, non-Hodgkin's lymphoma, Ewing's tumour, rhabdomyosarcoma, and (during 1981-84) osteosarComa treated at paediatric oncology centres had significantly higher survival rates than those treated elsewhere.
Current optimum management of anaplastic germ cell tumours of the testis and other sites.
TLDR
It is believed that POMB/ACE chemotherapy, followed by surgery in selected cases, is currently the best treatment for patients with AGCT.
Physician-dependent prognostic variables in the management of testicular cancer.
A study of 246 cases of germ cell testicular cancer in Ireland between 1980 and 1985 confirmed that the personnel and the manner of management can significantly influence the outcome. Inadequate
Influence of delay in diagnosis on prognosis in testicular teratoma.
TLDR
Analysis of relapse-free survival excluding stage I marker-negative patients gave results similar to those reported by the MRC Working Party on Testicular Tumours (1985).
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
TLDR
VIP combination chemotherapy demonstrates activity in this highly unfavorable population of patients with germ cell tumors, and these results compare favorably to the experience with similar patients treated with cisplatin plus VP-16 alone.
Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival.
TLDR
There were significant variations in patient outcome among surgeons after surgery for colorectal cancer; such differences compromise survival.
...
...